Data-Oriented, Non-Political Reimbursement In Japan: Wishful Thinking?
This article was originally published in The Gray Sheet
Executive Summary
Despite commitments from the Japanese advisory body Chuikyo, it remains to be seen whether Japan's comparative pricing system for medical devices will reflect reforms sought by U.S. companies, according to Pacific Bridge Medical President Ames Gross
You may also be interested in...
Japan May Seek Pricing Data From Other Asian Markets – MHLW Official
It would be difficult for Japan to extrapolate "meaningful" comparisons from planned device pricing surveys in other Asian markets, while the burden on manufacturers would increase substantially, according to Harold Smith, representative director of consulting firm L.E.K./Acumen Japan
Japan May Seek Pricing Data From Other Asian Markets – MHLW Official
It would be difficult for Japan to extrapolate "meaningful" comparisons from planned device pricing surveys in other Asian markets, while the burden on manufacturers would increase substantially, according to Harold Smith, representative director of consulting firm L.E.K./Acumen Japan
Japan May Seek Pricing Data From Other Asian Markets - MHLW Official
It would be difficult for Japan to extrapolate "meaningful" comparisons from planned device pricing surveys in other Asian markets, while the burden on manufacturers would increase substantially, according to Harold Smith, representative director of consulting firm L.E.K./Acumen Japan